|
Overview |
Product information |
Accredo services |
Contact team
Extavia is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Efficacy has been demonstrated for patients with multiple sclerosis who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.1
For more information, please visit Extavia.com, or download the medication guide for patients.
1. Extavia Prescribing Information - Novartis Pharmaceuticals Corporation 2009.
Extavia is a registered trademark of Novartis Pharmaceuticals Corporation.
| 
